Members of the National Assembly’s committees on health have described Emzor Pharmaceutical company as critical to health security for the many products it manufactures for the local market and for international consumers.
Chairman of the Senate Committee on Health, Dr Ibrahim Yahaya Oloriegbe gave the commendation when he led a delegation on a facility tour of the Sagamu factory, recently.
- Reps investigate leakages, explosions at oil fields
- BUK mass comm alumni to mark 40th anniversary with public lecture
Oloriegbe said the factory is a major achievement for the health security of the country.”
Also, the Chairman, House Committee on Health, Hon. Yusuf Tanko Sununu, said his confidence is restored in the health sector with the role Emzor was playing.
Emzor Executive Director, Pharmacist Uzoma Ezeoke, in a presentation on Emzor Group, said it started as a sales company and rose to manufacturing and exporting to Africa, Europe and America.
He also said Emzor now has API Manufacturing Technology Transfer and licensing agreement with India’s Mangalam Drugs & Organic Limited to locally manufacture and distribute Active Pharmaceutical ingredients (4 API’s) for the treatment and prevention of malaria.
Emzor is a privately owned indigenous pharmaceutical company founded in 1984 by Dr Stella Okoli.
The Company has grown into a legacy pharmaceutical company with four modern factories that manufacture over 260 world-class pharmaceutical products.
Emzor has a network of over 120 distributors covering public and private institutions across West Africa. Emzor is the largest indigenous pharmaceutical manufacturer in the country with over 120 products, all NAFDAC approved.
The factory is also (cGMP) compliant and has already manufactured and supplied millions of doses of medication ranging from antimalarials, paediatric care, vitamins and antiretrovirals to various international organizations through partnerships for public health intervention.